Amicus Therapeutics, Inc. is a global biotechnology company focused on discovering, developing, and delivering new, high-quality medicines for people with rare metabolic diseases. The company is committed to advancing and expanding its portfolio of advanced, first-in-class, or best-in-class therapies for rare metabolic disorders.
Get AI Stock Predictions Now
Download our app for real-time AI-powered stock predictions on iOS, Android, Windows and macOS
Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.